Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelley R Jordan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 18, 2025
Radiation Induces Pericyte-Myofibroblast TransitionTomoko Yamazaki, Kelley R Jordan, Nathaniel Fox, et al.
Cancer|July 6, 2018
Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbiditiesKelley R Jordan, Brett R Loman, Michael T Bailey, et al.
Brain, Behavior, and Immunity|September 26, 2021
Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in miceKyle A Sullivan, Corena V Grant, Kelley R Jordan, et al.
Behavioural Brain Research|December 6, 2020
Voluntary wheel running ameliorates select paclitaxel chemotherapy-induced sickness behaviors and associated melanocortin signalingKyle A Sullivan, Corena V Grant, Kelley R Jordan, et al.
Metabolic Brain Disease|January 7, 2021
Thrombin generation and activity in multiple sclerosisKelley R Jordan, Ivan Parra-Izquierdo, András Gruber, et al.
American Journal of Physiology. Cell Physiology|November 13, 2023
Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosisNorah G Verbout, Weiping Su, Peter Pham, et al.
Frontiers in Immunology|September 16, 2021
The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell InteractionsIván Parra-Izquierdo, Hari Hara Sudhan Lakshmanan, Alexander R Melrose, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2022
Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosisKelley R Jordan, Cory R Wyatt, Meghan E Fallon, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2024
Pharmacologic targeting of coagulation factors XII and XI by monoclonal antibodies reduces thrombosis in nitinol stents under flowNovella M Keeling, Michael Wallisch, Jennifer Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|March 7, 2022
Effects of ex vivo blood anticoagulation and preanalytical processing time on the proteome content of plateletsSamuel Tassi Yunga, Austin J Gower, Alexander R Melrose, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Radiation Oncology, Biology, Physics|June 18, 2025
Radiation Induces Pericyte-Myofibroblast TransitionTomoko Yamazaki, Kelley R Jordan, Nathaniel Fox, et al.
Cancer|July 6, 2018
Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbiditiesKelley R Jordan, Brett R Loman, Michael T Bailey, et al.
Brain, Behavior, and Immunity|September 26, 2021
Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in miceKyle A Sullivan, Corena V Grant, Kelley R Jordan, et al.
Behavioural Brain Research|December 6, 2020
Voluntary wheel running ameliorates select paclitaxel chemotherapy-induced sickness behaviors and associated melanocortin signalingKyle A Sullivan, Corena V Grant, Kelley R Jordan, et al.
Metabolic Brain Disease|January 7, 2021
Thrombin generation and activity in multiple sclerosisKelley R Jordan, Ivan Parra-Izquierdo, András Gruber, et al.
American Journal of Physiology. Cell Physiology|November 13, 2023
Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosisNorah G Verbout, Weiping Su, Peter Pham, et al.
Frontiers in Immunology|September 16, 2021
The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell InteractionsIván Parra-Izquierdo, Hari Hara Sudhan Lakshmanan, Alexander R Melrose, et al.
Journal of Thrombosis and Haemostasis : JTH|May 31, 2022
Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosisKelley R Jordan, Cory R Wyatt, Meghan E Fallon, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2024
Pharmacologic targeting of coagulation factors XII and XI by monoclonal antibodies reduces thrombosis in nitinol stents under flowNovella M Keeling, Michael Wallisch, Jennifer Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|March 7, 2022
Effects of ex vivo blood anticoagulation and preanalytical processing time on the proteome content of plateletsSamuel Tassi Yunga, Austin J Gower, Alexander R Melrose, et al.
Pageof 2